Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2018

Altered compensatory cytokine signaling underlies the
discrepancy between Flt3–/– and Flt3l–/– mice
Vivek Durai
Washington University School of Medicine in St. Louis

Prachi Bagadia
Washington University School of Medicine in St. Louis

Carlos G. Briseño
Washington University School of Medicine in St. Louis

Derek J. Theisen
Washington University School of Medicine in St. Louis

Arifumi Iwata
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Durai, Vivek; Bagadia, Prachi; Briseño, Carlos G.; Theisen, Derek J.; Iwata, Arifumi; Davidson, Jesse T.;
Gargaro, Marco; Fremont, Daved H.; Murphy, Theresa L.; and Murphy, Kenneth M., ,"Altered compensatory
cytokine signaling underlies the discrepancy between Flt3–/– and Flt3l–/– mice." Journal of Experimental
Medicine. 215,5. . (2018).
https://digitalcommons.wustl.edu/open_access_pubs/8515

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Vivek Durai, Prachi Bagadia, Carlos G. Briseño, Derek J. Theisen, Arifumi Iwata, Jesse T. Davidson, Marco
Gargaro, Daved H. Fremont, Theresa L. Murphy, and Kenneth M. Murphy

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/8515

ARTICLE

Altered compensatory cytokine signaling underlies
the discrepancy between Flt3–/– and Flt3l–/– mice
The receptor Flt3 and its ligand Flt3L are both critical for dendritic cell (DC) development, but DC deficiency is more severe
in Flt3l−/− mice than in Flt3−/− mice. This has led to speculation that Flt3L binds to another receptor that also supports DC
development. However, we found that Flt3L administration does not generate DCs in Flt3−/− mice, arguing against a second
receptor. Instead, Flt3−/− DC progenitors matured in response to macrophage colony–stimulating factor (M-CSF) or stem
cell factor, and deletion of Csf1r in Flt3−/− mice further reduced DC development, indicating that these cytokines could
compensate for Flt3. Surprisingly, Flt3−/− DC progenitors displayed enhanced M-CSF signaling, suggesting that loss of Flt3
increased responsiveness to other cytokines. In agreement, deletion of Flt3 in Flt3l−/− mice paradoxically rescued their severe
DC deficiency. Thus, multiple cytokines can support DC development, and the discrepancy between Flt3−/− and Flt3l−/− mice
results from the increased sensitivity of Flt3−/− progenitors to these cytokines.

Introduction

Dendritic cells (DCs) are immune cells with critical functions
in both the innate and adaptive immune responses that develop
from hematopoietic progenitor cells (Liu et al., 2007; Mildner
and Jung, 2014). The earliest committed progenitor with DC fate
potential is the macrophage/DC progenitor (MDP; Fogg et al.,
2006; Auffray et al., 2009), which develops into a common DC
progenitor (CDP) that can give rise to plasmacytoid DCs (pDCs) as
well as the classical DC (cDC) subsets, cDC1 and cDC2 (Naik et al.,
2007; Onai et al., 2007). Committed cDC progenitors restricted to
only the cDC1 or the cDC2 lineage have recently been identified
in mice (Grajales-Reyes et al., 2015; Schlitzer et al., 2015) and in
humans (Breton et al., 2015; Lee et al., 2015; See et al., 2017).
The development of DCs is dependent on the class III receptor
tyrosine kinase (RTK) Fms-like tyrosine kinase 3 (Flt3) and its
ligand Flt3L (McKenna et al., 2000; Waskow et al., 2008). Flt3
was first identified as a gene enriched in hematopoietic stem
cells that encoded a protein homologous to the receptor c-Kit
(Matthews et al., 1991). It was later recognized to be expressed on
mature DCs and their progenitors as well (Miller et al., 2012). Flt3
shares structural properties and downstream signaling pathways
with c-Kit and CSF1R, other members of the class III RTK family
that are also expressed by committed DC progenitors (Onai et al.,
2007; Verstraete and Savvides, 2012; Grajales-Reyes et al., 2015).
The ligand for Flt3, Flt3L, was subsequently cloned and found

to induce proliferation in early bone marrow (BM) progenitors
(Lyman et al., 1993). Later, a role for Flt3L in DC homeostasis
was uncovered from the expansion of DCs in mice and humans
who were administered this cytokine (Maraskovsky et al., 1996,
2000). Furthermore, treatment of BM progenitors in vitro with
Flt3L also supports the development of mature DCs (Brasel et
al., 2000; Naik et al., 2005), and Flt3+ progenitors preferentially
gave rise to DCs in vivo (D’Amico and Wu, 2003). Finally, genetic
inactivation of the Flt3 (Mackarehtschian et al., 1995) or Flt3l
(McKenna et al., 2000) genes in mice was observed to decrease
the numbers of DCs (McKenna et al., 2000; Waskow et al., 2008),
confirming their importance in DC homeostasis.
These original studies of Flt3−/− and Flt3l−/− mice surprisingly
appeared to find DC deficiencies of varying severity in these two
strains. Flt3l−/− mice analyzed between 5 and 14 wk of age had a 4to 10-fold reduction in splenic CD8α– DCs and a 6- to 14-fold reduction in splenic CD8α+ DCs (McKenna et al., 2000). Meanwhile, an
analysis of Flt3−/− mice found that although all DCs were reduced
by 85% at 2 wk of age, they were reduced by only 43% (cDCs) or
65% (pDCs) at 9 wk of age (Waskow et al., 2008). Another study
that examined both strains between 8 and 12 wk of age similarly
found more severe reductions in CD8α+ DCs and CD11b+ DCs in
Flt3l−/− mice compared with Flt3−/− mice (Ginhoux et al., 2009).
This discrepancy has also been noted in the development of
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DCs, and that the discrepancy between Flt3−/− and Flt3l−/− mice is
a result of the enhanced sensitivity of Flt3−/− BM progenitors to
signaling by these alternative cytokines.

Results

Flt3l−/− mice have a more severe DC deficiency
than Flt3−/− mice
The original studies that analyzed Flt3−/− and Flt3l−/− mice did not
directly compare these strains at similar ages, so the previously
noted phenotypic discrepancy may simply have been a result of
mismatched comparisons (McKenna et al., 2000; Waskow et al.,
2008). We therefore examined matched sets of Flt3−/− and Flt3l−/−
mice at both 2 and 8 wk of age (Figs. 1 and 2). We confirmed the
previous report of severe reductions in the percentage (Fig. 1, C
and E) and numbers (Fig. 1, D and F) of splenic cDCs and pDCs
at 2 wk in both Flt3−/− and Flt3l−/− mice. We also found severe
reductions in both populations in the skin-draining lymph nodes
(SLNs; Fig. S1, B and C) and lungs (Fig. S1 G) of these strains. Even
at this age, however, the defect in cDCs and pDCs was more severe
in Flt3l−/− mice than in Flt3−/− mice in all organs analyzed. We
also observed previously unrecognized heterozygous phenotypes
in both Flt3+/− and Flt3l+/− mice compared with WT mice. Flt3l+/−
mice showed a twofold reduction in DC numbers relative to WT
mice, whereas, surprisingly, Flt3+/− mice had significantly more
DCs than WT mice (Fig. 1, C–F).
In contrast, at 8 wk, Flt3−/− mice showed only a mild deficiency in the percentage and number of splenic DCs, whereas
Flt3l−/− mice continued having severely reduced DC populations
compared with both WT and Flt3−/− mice (Fig. 2, A–F). Findings
were similar for cDCs and pDCs in the SLNs (Fig. S1, D and E)
and for cDCs in the lungs (Fig. S1 H). Heterozygous phenotypes
were again observed at 8 wk, with Flt3l+/− mice showing a twofold
reduction in DCs compared with WT mice and Flt3+/− mice having consistently greater numbers of DCs compared with WT mice
(Fig. 2, A–F). In summary, the more severe DC defect in Flt3l−/−
mice compared with Flt3−/− mice appears to be an inherent difference between these strains.
Flt3L does not support DC development from Flt3−/− BM or
in Flt3−/− mice
To explain the discrepancy between Flt3−/− and Flt3l−/− mice,
some have suggested that Flt3L could support DC development
in Flt3−/− mice by acting on a second receptor, thus explaining
the less severe phenotype of Flt3−/− mice (Nagasawa, 2006; Helft
et al., 2010; Satpathy et al., 2011; Moore and Anderson, 2013;
Tsapogas et al., 2017). To test for evidence of a second Flt3L
receptor, we cultured WT and Flt3−/− BM in vitro with Flt3L and
assessed DC development, hypothesizing that Flt3L could bind
to its second receptor in Flt3−/− BM and generate DCs. However, although Flt3L supported robust DC development from
WT BM, it did not generate DCs from Flt3−/− BM (Fig. 3, A–E).
Thus, in vitro, we were unable to provide evidence for a second
receptor responding to Flt3L. We next administered Flt3L in vivo
(Fig. 3, F–J). Flt3L administration to WT mice caused a significant increase in the percentage and numbers of splenic DCs, as
expected (Maraskovsky et al., 1996), but failed to increase DCs
Journal of Experimental Medicine
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pre-pro-B cells, with Flt3l−/− mice demonstrating a severe reduction in this population, whereas Flt3−/− mice had only a twofold
reduction (Mackarehtschian et al., 1995; Sitnicka et al., 2002,
2003; Nagasawa, 2006). However, no study has directly compared Flt3−/− mice with Flt3l−/− mice over time, so it is unknown
whether the defects caused by Flt3L deficiency improve with age,
as with Flt3 deficiency, or whether Flt3−/− mice and Flt3l−/− mice
simply have distinct phenotypes. Nevertheless, these apparent
discrepancies in phenotypes have led to suggestions that Flt3L
could act on a second receptor other than Flt3 to support DC or B
cell development, explaining the more severe defects in Flt3l−/−
mice (Nagasawa, 2006; Helft et al., 2010; Satpathy et al., 2011;
Moore and Anderson, 2013; Tsapogas et al., 2017).
Cytokines such as Flt3L can play supportive and instructive roles in the development of hematopoietic lineages (Enver
et al., 1998; Metcalf, 1998), and the actions of a given cytokine
may depend upon the progenitor stage and cell type it acts upon
(Rieger et al., 2009; Mossadegh-Keller et al., 2013). For DCs,
an instructive role for Flt3 was suggested by the redirection of
megakaryocyte-erythrocyte progenitors (MEPs) toward DC
fate upon forced Flt3 overexpression (Onai et al., 2006) and by
transgenic mice in which Flt3L overexpression leads to a robust
expansion of DCs, lymphocytes, and myeloid cells at the expense
of erythrocytes and platelets (Tsapogas et al., 2014). Nonetheless,
Flt3L administration does not increase in vivo DC output from
early Flt3+ progenitors such as common lymphoid progenitors,
common myeloid progenitors, or granulocyte-monocyte progenitors (Karsunky et al., 2003), and the continued presence of DCs
in Flt3−/− and Flt3l−/− mice, albeit at reduced numbers, suggests
that DC development can occur through some unidentified mechanism in the absence of this cytokine pathway. Thus, it remains
unclear what specific role Flt3L plays in DC progenitor specification and development, as well as whether any other cytokines can
contribute to this process.
To address the apparent discrepancy in phenotypes between
Flt3−/− and Flt3l−/− mice, we directly compared DC development
in these strains over time. We confirmed that Flt3l−/− mice show a
severe and persistent DC defect, whereas Flt3−/− mice have a less
severe defect at all ages analyzed. However, we were unable to
demonstrate activity for Flt3L on a second receptor as has been
proposed. Instead, we found that DC progenitors developed normally without instructional cues from Flt3 signaling and, surprisingly, that these progenitors could mature in Flt3−/− mice in
response to macrophage colony–stimulating factor (M-CSF) and
stem cell factor (SCF), ligands for other class III RTKs expressed
by these cells. Deletion of Csf1r in Flt3−/− mice also led to a further
reduction in DC development in a cell-intrinsic manner, indicating that this cytokine pathway was partially compensating for
the loss of Flt3 in vivo. Although the expression of CSF1R and
c-Kit was not altered in Flt3−/− progenitors, we found that these
progenitors were more responsive to stimulation by M-CSF, suggesting that the absence of Flt3 potentiates signaling by other
class III RTKs. To test whether this effect was responsible for
the discrepancy between Flt3−/− and Flt3l−/− mice, we generated
Flt3−/−Flt3l−/− mice and found that the additional deletion of Flt3
paradoxically restored DC numbers in Flt3l−/− mice. We conclude
that multiple cytokine pathways can support the development of
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in Flt3−/− mice (Fig. 3, F–J). In summary, we find no evidence for
actions of Flt3L on a second receptor.
Because DCs in Flt3−/− mice appeared to arise independently of
Flt3L, we wondered whether they were developmentally or functionally impaired. We therefore examined the transcriptional
profile of splenic cDC1s and cDC2s from WT and Flt3−/− mice
using gene expression microarrays. We found no substantial
Durai et al.
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Figure 1. Flt3l−/− mice have a more severe DC deficiency than Flt3−/− mice at two weeks of age. (A and B) Splenocytes from mice of the indicated genotypes at 2-wk of age were analyzed by flow cytometry for DC populations. Shown are representative two-color histograms of live cells. Numbers specify the
percentage of cells within the indicated gates. (C–F) Summary data for the percentage (C) and number (D) of splenic cDCs and the percentage (E) and number
(F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from seven
independent experiments (n = 5 mice per genotype). *, P < 0.05; **, P < 0.01; ****, P < 0.0001 using unpaired, two-tailed Student's t test.

changes in gene expression in either cDC subset, with the only
annotated transcript showing a greater-than fourfold change
being Flt3 itself (Fig. 4, A and B). In addition, we found that
Flt3−/− cDC1s were able to cross-present cell-associated and soluble antigen to CD8 T cells as efficiently as WT cDC1s (Fig. 4, C–E),
suggesting they were functionally similar. We next examined the
transcriptional profile of splenic pDCs from WT and Flt3−/− mice
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20171784
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(Fig. 4 F). We again found only minor differences between these
populations, with Flt3 being the only annotated transcript showing a greater-than fourfold increase in expression in WT pDCs
and with several genes encoding Igκ segments being more highly
expressed in Flt3−/− pDCs. pDCs have been found to develop from
both myeloid and lymphoid progenitors (Sathe et al., 2013),
with pDCs derived from lymphoid progenitors showcasing rearrangements of D-J segments in the immunoglobulin genes. The
Durai et al.
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Figure 2. Flt3l−/− mice continue to have a more severe DC deficiency than Flt3−/− mice at eight weeks of age. (A and B) Splenocytes from mice of the
indicated genotypes at 8-wk of age were analyzed by flow cytometry for DC populations. Shown are representative two-color histograms of live cells. Numbers
specify the percentage of cells within the indicated gates. (C–F) Summary data for the percentage (C) and number (D) of splenic cDCs and the percentage (E)
and number (F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are
pooled from nine independent experiments (n = 5–9 mice per genotype). *, P < 0.05; **, P < 0.01; ****, P < 0.0001 using unpaired, two-tailed Student's t test.

increased expression of these genes encoding Igκ segments in
Flt3−/− pDCs could therefore indicate that the pDCs in Flt3−/− mice
preferentially arise from lymphoid rather than myeloid progenitors. Other than these genes, we found that the expression of the
vast majority of transcripts was similar between WT and Flt3−/−
pDCs (Fig. 4 F). Finally, we stimulated WT and Flt3−/− pDCs with
CpG oligodeoxynucleotides and found that both populations produced a comparable amount of IFN-α (Fig. 4 G). Together, these
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20171784
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Figure 3. Flt3L fails to generate DCs in Flt3−/− mice. (A–E) BM cells from WT (Flt3+/+) or Flt3−/− mice were treated with vehicle or Flt3L and cultured for 9
d. Live cells were subsequently analyzed by flow cytometry for DC populations. (A) Shown are representative two-color histograms of live cells pregated as
indicated above the plots. Numbers specify the percentage of cells within the indicated gates. (B–E) Summary data for the percentage (B) and number (C) of
cDCs in each culture and for the percentage (D) and number (E) of pDCs in each culture. Dots represent biological replicates; small horizontal lines indicate
the mean. Data are pooled from three independent experiments (n = 4 mice per genotype). (F–J) WT (Flt3+/+) and Flt3−/− mice were administered vehicle or
Flt3L subcutaneously for 8 d and splenocytes were subsequently analyzed by flow cytometry on day 9 for DC populations. (F) Shown are representative twocolor histograms of live cells. Numbers specify the percentage of cells within the indicated gates. (G–J) Summary data for the percentage (G) and number (H)
of splenic cDCs and the percentage (I) and number (J) of splenic pDCs. Dots represent biological replicates; small horizontal lines indicate the mean. Data are
pooled from two independent experiments (n = 5 mice per group). ns, not significant (P > 0.05); *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using
unpaired, two-tailed Student's t test.
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results suggest that the DCs in Flt3−/− mice are transcriptionally
and functionally similar to WT DCs, implying that Flt3 signaling
is not essential for generating functional DCs.

Figure 4. Flt3−/− DCs are transcriptionally and functionally similar to WT DCs. (A and B) Microarray analysis of gene expression in cDC1s (A) or cDC2s (B)
from Flt3+/+ and Flt3−/− mice, presented as M-plots. Colors indicate higher (red) or lower (blue) expression in Flt3+/+ cells than in Flt3−/− cells. Annotated genes
with a greater than fourfold change in expression are specified (n = 2 biological replicates per subset per genotype). (C) Sorted cDC subsets from Flt3+/+ or
Flt3−/− mice were cultured for 3 d with CFSE-labeled OT-I cells and different doses of heat-killed LM-OVA (HKLM-OVA) and then assayed for OT-I proliferation
(CFSE–CD44+). Summary data for the percentage of proliferated OT-I cells in cultures with cDC subsets from the indicated genotypes are shown. Data are pooled
from two independent experiments (n = 4 mice per genotype). (D) Sorted cDC subsets from Flt3+/+ or Flt3−/− mice were cultured for 3 d with CFSE-labeled OT-I
cells and different doses of soluble OVA as antigen and then assayed for OT-I proliferation (CFSE–CD44+). Summary data for the percentage of proliferated
OT-I cells in cultures with cDC subsets from the indicated genotypes are shown. Data are pooled from two independent experiments (n = 4 mice per genotype). (E) Sorted cDC subsets from Flt3+/+ or Flt3−/− mice were incubated with soluble OVA, washed, and then different numbers of cDCs were cultured with
CFSE-labeled OT-I cells for 3 d after which OT-I proliferation was assayed. Summary data for the percentage of proliferated OT-I cells in cultures with the cDC
subsets from the indicated genotypes are shown. Dots represent the mean; error bars represent the SEM. Data are pooled from two independent experiments
(n = 4 mice per genotype). (F) Microarray analysis of gene expression in pDCs from Flt3+/+ and Flt3−/− mice, presented as M-plots. Colors indicate higher (red)
or lower (blue) expression in Flt3+/+ cells than in Flt3−/− cells. Annotated genes with a greater than fourfold change in expression are specified (n = 2 biological
replicates per subset per genotype). (G) Sorted pDCs from Flt3+/+ or Flt3−/− mice were stimulated with vehicle or CpG-A oligodeoxynucleotides overnight and
then the cell supernatant was analyzed for IFN-α production. Summary data for the quantity of IFN-α produced by pDCs of the indicated genotypes are shown.
Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from two independent experiments (n = 4 mice per genotype).
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Committed DC progenitors develop in Flt3−/− BM and can
mature in response to M-CSF and SCF
We next considered whether Flt3−/− DCs could be maturing in
response to alternative cytokines. The receptors for M-CSF
(CD115/CSF1R) and for SCF (CD117/c-Kit) are both expressed by
the MDP and CDP (Liu et al., 2009), suggesting that these cytokines could act on these progenitors, and M-CSF has also been
reported to support the development of some DC subsets in vitro
(Fancke et al., 2008). To help identify cDCs in the Flt3−/− background, we crossed Flt3−/− mice to Zbtb46GFP/+ mice to generate
Flt3−/−Zbtb46GFP/+ mice, in which we could use Zbtb46GFP expression to distinguish cDCs from other lineages (Meredith et al.,
2012; Satpathy et al., 2012; Wu et al., 2016). We then cultured
bulk BM from WT (Flt3+/+Zbtb46GFP/+), Flt3+/−Zbtb46GFP/+, and
Flt3−/−Zbtb46GFP/+ mice with Flt3L, M-CSF, or SCF and assessed
DC development. Surprisingly, we found that all three cytokines
supported the development of cDC1s and cDC2s from WT and
Flt3+/− BM, whereas M-CSF and SCF also supported cDC development from Flt3−/− BM (Fig. 5, A and B). Notably, M-CSF and
SCF generated a greater percentage (Fig. 5 B) and number (Fig.
S2 A) of cDCs from Flt3−/− BM than from WT BM, suggesting that
Flt3−/− BM may be more responsive to these cytokines than WT
BM. Importantly, the cDCs generated in all cultures were uniformly positive for Zbtb46GFP expression (Fig. 5 A), confirming
their identity as bona fide cDCs (Meredith et al., 2012; Satpathy
et al., 2012; Wu et al., 2016).
To further characterize these cells and to identify any heterogeneity in the populations, we examined the expression of a variety of functional markers in cDCs from each culture condition.
We found that the cDCs generated in response to each cytokine
generally expressed similar levels of costimulatory molecules
such as CD86, PD-L2, CD40, and CD205; surface markers such as
CD24, CD172a, and CD11b; and DC-specific markers such as Flt3/
CD135 (the cDCs from Flt3L cultures expressed low levels of this
receptor, potentially caused by down-regulation after exposure
to Flt3L), CCR7, and CD117, and that they all expressed similarly

low levels of macrophage markers such as CD115 and CD64 (Fig.
S2 B). Thus, we concluded that the cDCs that mature in response
to M-CSF and SCF are generally similar in phenotype to those
that are generated by Flt3L. Finally, we found that Flt3L, M-CSF,
and SCF could all support pDC development from WT BM and
that M-CSF and SCF could also support pDC development from
Flt3−/− BM (Fig. S3 A).
Because mature DCs could be generated from the BM of Flt3−/−
mice, we wondered whether DC progenitor specification was
occurring normally in these mice. Identifying the CDP relies on
Flt3 expression (Onai et al., 2007) and is therefore not possible
in Flt3−/− mice. However, two restricted cDC progenitors downstream of the CDP, pre-cDC1 and pre-cDC2, can be identified with
Zbtb46GFP expression and additional markers without the need
for Flt3 (Grajales-Reyes et al., 2015). We therefore analyzed BM
from Flt3−/−Zbtb46GFP/+ mice to identify these progenitors and
found normal frequencies of pre-cDC1s and pre-cDC2s compared
with Flt3+/+Zbtb46GFP/+ mice (Fig. 5 C). As a control, BM from
Irf8−/−Zbtb46GFP/+ mice lacked pre-cDC1s and had reduced precDC2s, as expected (Grajales-Reyes et al., 2015). Thus, cDC progenitor specification appears to be independent of Flt3 signaling.
We next asked whether M-CSF and SCF could act directly
on committed DC progenitors to support their maturation. To
address this question, we sort purified WT CDPs, which express
Flt3, CSF1R, and c-Kit, and cultured them with Flt3L, M-CSF, or
SCF. These cytokines each supported development of the CDP into
mature Zbtb46GFP-positive cDC1s and cDC2s (Fig. 6 A) as well as
pDCs (Fig. S3 B). In addition, pre-cDC2s, which normally express
CSF1R and Flt3, were isolated from Flt3+/+Zbtb46GFP/+ mice and
Flt3−/−Zbtb46GFP/+ mice and cultured with Flt3L or M-CSF. As
expected, Flt3L supported development of the pre-cDC2 into
mature Zbtb46GFP-positive cDC2s from WT progenitors but not
from Flt3−/− progenitors (Fig. 6 B). In contrast, M-CSF supported
development of the pre-cDC2 into Zbtb46GFP-positive cDC2s
from both WT and Flt3−/− progenitors (Fig. 6 B). When we analyzed cell divisions using cell proliferation dye tracing, we found
that, when cultured with M-CSF, Flt3−/− pre-cDC2s proliferated
more than WT pre-cDC2s (Fig. 6 C), again suggesting that Flt3−/−
progenitors were more responsive to M-CSF than WT progenitors. Thus, our data suggest that specified DC progenitors that
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Figure 5. Flt3−/− BM generates mature DCs in response to M-CSF or SCF and contains committed DC progenitors. (A and B) BM cells from mice of the
indicated genotypes were treated with vehicle, Flt3L, M-CSF, or SCF and cultured for 7 d. Live cells were subsequently analyzed by flow cytometry for development of DCs. (A) Shown are representative two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP
expression in cells of the indicated subtype. Numbers represent the percentage of cells within the indicated gates. (B) Summary data for the percentage of
cDCs in each culture. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from five independent experiments (n =
5–7 mice per genotype). (C) BM cells from mice of the indicated genotypes were analyzed by flow cytometry for DC progenitor populations; lineage markers
include CD3, CD19, CD105, Ter119, and Ly-6G. Representative two-color histograms are shown of live cells pregated as indicated above the plots. Numbers
specify the percentage of cells within the indicated gates. Data are representative of four independent experiments (n = 7 mice per genotype). ns, not significant
(P > 0.05); **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using unpaired, two-tailed Student's t test.
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develop in the presence or absence of Flt3 signaling can mature
in response to cytokines other than Flt3L.

Flt3−/− progenitors express normal levels of CSF1R and c-Kit
but display enhanced signaling from these receptors
Because M-CSF and SCF could support DC development independently of Flt3, we wondered whether the discrepancy
between Flt3−/− and Flt3l−/− mice might be a result of differences
in the expression or signaling of CSF1R or c-Kit in these different strains. First, we found no differences in surface expression of CSF1R or c-Kit in total BM isolated from WT, Flt3−/−, and
Flt3l−/− mice (Fig. 8 A). We next sought to quantify the expression of these receptors in early DC progenitors, but because Flt3
is required to identify the MDP and CDP (Onai et al., 2007), we
could not analyze these progenitors in Flt3−/− mice. We therefore
generated Flt3l−/−Zbtb46GFP/+ mice to identify the pre-cDC1 and
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DC development in Flt3−/− mice is substantially
dependent on CSF1R
To determine whether M-CSF supported the in vivo DC development observed in Flt3−/− mice, we deleted Csf1r (Li et al., 2006)
in WT and Flt3−/− mice using a tamoxifen-inducible Cre recombinase (Ventura et al., 2007). Deletion of Csf1r in WT mice caused
a small decrease in splenic cDC percentage and numbers, consistent with a previous study describing a minor role for CSF1R
in cDC homeostasis (Fig. 7, A, C, and D; Ginhoux et al., 2009).
In contrast, deletion of Csf1r in Flt3−/− mice led to a substantial
reduction in cDCs (Fig. 7, B–D), confirming that cDCs developing in Flt3−/− mice arise in part through the actions of CSF1R.
pDC development, however, was unaffected by the additional
deletion of Csf1r (Fig. 7, E and F), consistent with prior studies
showing that pDC progenitors are enriched in the CSF1R– fraction
of BM progenitors (Onai et al., 2013) and that almost all pDCs
are derived from an IL-7R+ progenitor (Schlenner et al., 2010).
Our gene expression data had also indicated that the pDCs in
Flt3−/− mice may be preferentially developing from lymphoid
progenitors (Fig. 4 F), which, combined with the lack of a role for
CSF1R, suggests that the pDCs in Flt3−/− mice may be developing
in response to compensatory signaling from a receptor expressed
on lymphoid progenitors such as IL-7R. In summary, a substantial portion of cDC but not pDC development in Flt3−/− mice is
dependent on CSF1R.
To test whether this action of CSF1R was cell-intrinsic to DC
progenitors, we generated mixed BM chimeras with a 50:50 mix
of Flt3−/− BM and either Flt3−/−Csf1rf/fR26+/+ BM (CreERT2–) or
Flt3−/−Csf1rf/fR26CreERT2/+ BM (CreERT2+). Although all BM progenitors in these chimeras were deficient in Flt3, tamoxifen
treatment led to the additional deletion of CSF1R in half of the
BM cells in CreERT2+ chimeras but not in CreERT2– chimeras
(Fig. 7 G). Thus, we could directly compare the DC potential of
progenitors lacking both Flt3 and CSF1R with progenitors lacking only Flt3. In CreERT2+ chimeras, cDCs preferentially developed from Flt3−/− BM cells, rather than from Flt3−/−Csf1r−/− BM,
whereas in CreERT2– chimeras there was no skew in DC development between Flt3−/− and Flt3−/−Csf1rf/fR26+/+ BM (Fig. 7, G
and H). This result suggests that the contribution of CSF1R to DC
development in Flt3−/− progenitors is cell-intrinsic.

pre-cDC2 in Flt3l−/− mice, which would allow us to compare these
progenitors in WT, Flt3−/−, and Flt3l−/− mice. We found that both
progenitors still developed in Flt3l−/− mice, but were substantially fewer in number relative to WT and Flt3−/− mice (Fig. S4
A). This was similar to the reported deficiency in MDPs and CDPs
in Flt3l−/− mice (Kingston et al., 2009), suggesting that all DC progenitors are affected by the loss of Flt3L. We found, however, that
the expression of CSF1R and c-Kit was not different in pre-cDC1s
or pre-cDC2s from Flt3−/− or Flt3l−/− mice relative to WT mice
(Fig. 8 B), again suggesting that changes in receptor expression
did not explain the differences between these strains. Finally, we
sought to determine the expression of these receptors in mature
splenic cDCs from these strains, but as collagenase digestion of
the spleen impairs detection of these receptors by FACS (Merad
et al., 2013), we instead used gene expression microarrays. We
found no differences in Csf1r or Kit gene expression in splenic
cDC1s or cDC2s from WT, Flt3−/−, and Flt3l−/− mice (Fig. 8 C). Thus,
we excluded differences in receptor expression as a cause of the
discrepancy between Flt3−/− and Flt3l−/− mice.
The in vitro DC development supported by M-CSF and SCF
was greater in Flt3−/− BM relative to WT BM (Fig. 5 B), and Flt3−/−
pre-cDC2s proliferated more than WT pre-cDC2s in response to
M-CSF (Fig. 6 C), suggesting there was some alteration in receptor sensitivity between WT and Flt3−/− mice. Flt3, CSF1R, and c-Kit
are all class III RTKs that share signaling adaptor molecules such
as Shc and Grb2 (Dosil et al., 1993; Rottapel et al., 1994; Verstraete
and Savvides, 2012; Tsapogas et al., 2017). We wondered whether
the loss of Flt3 might increase the availability of these adaptors
and thereby enhance signaling from CSF1R or c-Kit. To test this,
we quantified the sensitivity of CSF1R signaling in BM progenitors. We treated serum-starved BM cells from Flt3+/+, Flt3+/−, or
Flt3−/− mice with varying concentrations of M-CSF and quantified phosphorylation of the MAPK pathway protein Erk1/2 in
pre-cDC2s (Fig. 9 A). We examined this progenitor because it
expresses CSF1R and can be identified independently of Flt3 by
using Zbtb46-GFP expression (Grajales-Reyes et al., 2015). Over
a range of concentrations, both the percentage of pre-cDC2s
responding to M-CSF and the intensity of signaling in each progenitor was greater in Flt3−/− pre-cDC2s compared with Flt3+/+
pre-cDC2 cells, with Flt3+/− pre-cDC2s displaying an intermediate phenotype (Fig. 9, A and B). Thus, the loss of Flt3 directly
enhances the sensitivity and strength of CSF1R signaling in
response to M-CSF. Importantly, no differences were observed
in M-CSF signaling sensitivity in Flt3l−/− pre-cDC2s relative to
WT for most concentrations of M-CSF (Fig. S4 B), indicating that
the increased sensitivity to M-CSF was specific to Flt3−/− mice
and could possibly explain the difference between these mice and
Flt3l−/− mice.
Deletion of Flt3 in Flt3l−/− mice paradoxically
restores DC development
The increased sensitivity of CSF1R signaling in Flt3−/− DC progenitors could explain the discrepancy in DC numbers between
Flt3−/− and Flt3l−/− mice. Flt3−/− DC progenitors could respond
more robustly to alternative cytokines such as M-CSF or SCF
and thus develop greater numbers of DCs. This hypothesis predicts that the increased CSF1R sensitivity in Flt3−/− mice should
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Discussion

In this study, we have identified the previously unknown cytokine pathways that support the residual DC development seen in
Flt3−/− and Flt3l−/− mice, and we provide an explanation for the
puzzling discrepancy in phenotypes between these two strains.
Although both Flt3 and Flt3L have long been recognized to play
major roles in DC homeostasis (McKenna et al., 2000; Waskow
et al., 2008), it had remained unclear through what mechanism
DCs continue to arise in mice deficient in either of these factors.
We have demonstrated here that M-CSF and SCF, two cytokines
whose receptors are expressed in DC progenitors, are capable
of generating DCs from both WT and Flt3−/− BM progenitors in
vitro. We also found that a substantial fraction of the DCs that
arise in vivo in Flt3−/− mice are dependent on CSF1R for their
development, with c-Kit possibly responsible for generating the
remainder of the DCs.
These findings, along with the continued presence of committed DC progenitors in Flt3−/− mice, suggest that DC lineage
commitment may not require the Flt3 pathway and that multiple cytokines can provide the supportive signals necessary for
the maturation of these progenitors. Furthermore, the DCs that

develop in Flt3−/− mice were functional and had transcriptional
profiles indistinguishable from WT DCs, suggesting that the
actions of Flt3L in DC development can be compensated entirely
by other cytokines. Though we had originally hypothesized that
WT DCs would possess a gene signature indicative of their maturation in response to Flt3 signaling, that we did not see such a
signature or a corresponding gene signature suggestive of M-CSF
signaling in the Flt3−/− DCs suggests that these cytokines may not
impose any long-lasting genetic instruction upon mature DCs,
but instead simply support their development. DCs are therefore another example of a lineage that continues to develop and
function in the absence of its principal growth factor, similar
to granulocytes (Lieschke et al., 1994), erythrocytes (Wu et al.,
1995), and lymphocytes (Peschon et al., 1994; von Freeden-Jeffry
et al., 1995). Findings such as these help elucidate the precise role
of cytokines in hematopoietic lineage commitment and suggest
at least some level of promiscuity between cytokine pathways
and cell types.
Loss of a receptor and its unique ligand would generally be
expected to produce the same phenotype. However, our direct
comparison of Flt3−/− and Flt3l−/− mice clearly documents that
loss of the ligand causes a more severe and durable DC deficiency than loss of the receptor. We were unable to find evidence
to support previous suggestions that Flt3L might be acting at a
second receptor beside Flt3 (Nagasawa, 2006; Helft et al., 2010;
Satpathy et al., 2011; Moore and Anderson, 2013; Tsapogas et al.,
2017). Instead, we found that Flt3−/− DC progenitors exhibit an
intrinsic alteration in the sensitivity of other cytokine receptors
compared with WT progenitors. This may allow compensatory
cytokines such as M-CSF and SCF to generate a greater number
of DCs in Flt3−/− mice relative to WT or Flt3l−/− mice. We therefore predicted, and then validated, the paradoxical result that the
severe DC defect in Flt3l−/− mice is actually restored upon deletion
of Flt3. Thus, it appears that the discrepancy in DC development
between Flt3−/− and Flt3l−/− mice arises secondary to a phenotype
of increased sensitivity of Flt3−/− DC progenitors to alternative
cytokines. It is possible that a similar increase in sensitivity to
IL-7 in early B cell progenitors could explain the previously identified discrepancy in B cell development between these strains
(Nagasawa, 2006).
The increased sensitivity of Flt3+/− progenitors to M-CSF
(Fig. 9) might also explain the increased DC numbers we
observed in Flt3+/− mice (Figs. 1 and 2). Flt3+/− BM produced DCs
in response to Flt3L as well as to M-CSF (Fig. 5 B), so the increased

Figure 6. Committed DC progenitors can mature in response to M-CSF and SCF. (A) CDPs (Lin–CD117intCD135+CD115+CD11c–MHCII–) were sorted from
Zbtb46GFP/+ mice and cultured with vehicle, Flt3L, M-CSF, or SCF for 5 d. Cells were subsequently analyzed by flow cytometry for development of DCs. Shown
are representative two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP expression. Numbers specify
the percentage of cells within the indicated gates. Data are representative of three independent experiments (sorted cells from three to five mice were pooled
in each individual experiment). (B) Pre-cDC2s (Lin–CD115+CD11c+MHCII–Zbtb46+) were sorted from Flt3+/+Zbtb46GFP/+ or Flt3−/−Zbtb46GFP/+ mice as indicated
and cultured with vehicle, Flt3L, or M-CSF for 5 d. Cells were subsequently analyzed by flow cytometry for development of DCs. Shown are representative
two-color histograms of live cells pregated as indicated above the plots and one-color histograms of Zbtb46GFP expression in cells of the indicated subtype.
Numbers specify the percentage of cells within the indicated gates. Data are representative of three independent experiments (sorted cells from three to five
mice per genotype were pooled in each individual experiment). (C) Pre-cDC2s were sorted from Flt3+/+Zbtb46GFP/+ or Flt3−/−Zbtb46GFP/+ mice, labeled with Cell
Proliferation Dye (CPD), and cultured with M-CSF for 5 d. Cells were subsequently analyzed by flow cytometry for dilution of CPD to determine the number of
divisions they underwent. Shown is a representative one-color histogram of CPD levels and the percentage of cells at each division. Data are representative of
two independent experiments (sorted cells from three mice per genotype were pooled in each individual experiment).
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occur regardless of the presence of Flt3L and thus that loss of
Flt3 in the Flt3l−/− background should enhance CSF1R signaling
and potentially increase DC numbers. To test this hypothesis, we
crossed Flt3−/− and Flt3l−/− mice to generate Flt3−/−Flt3l−/− mice
and characterized DC development in the resulting littermates.
We first found that, unlike Flt3+/− mice, Flt3+/−Flt3l+/− mice had
mildly reduced DC numbers (Fig. 10, A–E). This suggests that the
decrease in DCs we found in Flt3l+/− mice (Figs. 1 and 2) was more
impactful than the increase in DCs observed in Flt3+/− mice (Figs.
1 and 2) and that together these alleles resulted in a net decrease
in DC numbers in Flt3+/−Flt3l+/− mice. But most surprisingly, we
found that Flt3−/−Flt3l−/− mice had an increase in splenic cDC and
pDC percentage and numbers relative to Flt3l−/− mice and were
indistinguishable from Flt3−/− mice (Fig. 10, A–E). This increase
was also observed in cDCs and pDCs in the SLNs (Fig. S5, A and B),
as well as in cDCs in the lung (Fig. S5 C). Thus, paradoxically, the
severe DC deficiency observed in Flt3l−/− mice was rescued by the
additional loss of Flt3. These results suggest that the discrepancy
observed between Flt3−/− and Flt3l−/− mice is, at least in part, a
result of an inherent alteration in the response of DC progenitors
to alternative cytokines secondary to the loss of Flt3.
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Materials and methods

Mice
All mice were bred and maintained on the C57BL/6 background
in a specific pathogen-free animal facility following institutional guidelines and with protocols approved by the Animal
Studies Committee at Washington University in St. Louis.
Unless otherwise specified, experiments were performed with
mice 6- to 10-wk of age. No differences were observed between
male and female mice in any assays and so mice of both genders were used throughout this study. Within individual experiments, mice used were age- and sex-matched littermates
whenever possible.
Flt3−/− mice (Mackarehtschian et al., 1995) were a gift from
E. Camilla Forsberg (University of California, Santa Cruz, Santa
Cruz, CA). Zbtb46GFP/+ mice have been previously described
(Satpathy et al., 2012; Grajales-Reyes et al., 2015). The following mice were purchased from The Jackson Laboratory: Flt3l−/−
(C57BL/6-Flt3ltm1Imx/TacMmjax), CD45.1+ (B6.SJL-Ptprca
Pepcb/BoyJ), OT-I (C57BL/6-Tg(TcraTcrb)1100Mjb/J), Csf1rf/f

(B6.Cg-Csf1rtm1.2Jwp/J), and R26CreERT2/+ (B6.129-Gt(ROSA)26
Sortm1(cre/ERT2)Tyj/J).
DC preparation
Lymphoid and nonlymphoid organ DCs were harvested and prepared as described previously (Satpathy et al., 2012). In brief,
spleens and SLNs (inguinal, axillary, and brachial) were minced
and digested in 5 ml IMDM + 10% FCS (cIMDM) with 250 µg/ml
collagenase B (Roche) and 30 U/ml DNase I (Sigma-Aldrich) for
45 min at 37°C with stirring. Lungs were minced and digested in
5 ml of cIMDM with 4 mg/ml collagenase D (Roche) and 30 U/
ml DNase I (Sigma-Aldrich) for 1.5 h at 37°C with stirring. After
digestion, cell suspensions from all organs were passed through
70-µm strainers and red blood cells were then lysed with ammonium chloride-potassium bicarbonate lysis buffer. Cells were
counted with a Vi-CELL analyzer (Beckman Coulter) and 3–5 ×
106 cells were used per antibody-staining reaction.
For experiments requiring sorting of splenic cDC subsets,
cDCs were first enriched from total spleen cells with CD11c
microbeads (Miltenyi Biotec). cDCs were then sorted on a flow
cytometer (FACSAria Fusion; BD Biosciences). cDC1s were sorted
as CD11c+MHC-II+CD24+CD172a–F4/80–, and cDC2s were sorted
as CD11c+MHCII+CD24–CD172a+F4/80–. Sort purity of >95% was
confirmed by post-sort analysis before cells were used for further experiments.
For experiments requiring sorting of splenic pDC subsets,
spleen cells were first depleted of CD3-, B220-, and Ly6G-expressing cells by staining with the corresponding biotinylated
antibodies followed by depletion with MagniSort Streptavidin
Negative Selection beads (Thermo Fisher). pDCs were then sorted
on a FACSAria Fusion flow cytometer as B220+CD317+. Sort purity
of >95% was confirmed by post-sort analysis before cells were
used for further experiments.
Antibodies and flow cytometry
Samples were stained at 4°C in MACS buffer (DPBS + 0.5% BSA +
2 mM EDTA) in the presence of Fc block (2.4G2; BD Biosciences).
The following antibodies were purchased from BD Biosciences:
CD8α V450 (53-6.7); CD11b PE (M1/70); CD19 Biotin (1D3); CD44
APC-Cy7 (IM7); CD45R Alexa Fluor 488; V450 (RA3-6B2); CD45.2
PerCP-Cy5.5 (104); CD64 Alexa Fluor 647 (X54-5/7.1); CD103
BV421 (M290); CD117 BUV395 (2B8); CD127 BV421 (SB/199); CD135
PE-CF594 (A2F10.1); Ly-6C Alexa Fluor 700 (AL-21); and I-A/I-E
V500 (M5/114.15.2). From eBioscience: CD11c PE (N418); CD44

Figure 7. cDC development in Flt3−/− mice is dependent on CSF1R. (A–F) Mice of the indicated genotypes were treated with tamoxifen to delete Csf1r. After
treatment, splenocytes were analyzed by flow cytometry for DC populations. (A and B) Shown are representative two-color histograms of live cells. Numbers
specify the percentage of cells within the indicated gates. (C–F) Summary data of the percentage (C) and number (D) of splenic cDCs and for the percentage
(E) and number (F) of splenic pDCs in mice of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data
are pooled from seven independent experiments. (n = 3–7 mice per genotype). (G and H) WT CD45.1+ mice were lethally irradiated and reconstituted with
Flt3−/− CD45.1+:Flt3−/−Csf1rf/fR26+/+CD45.2+ BM at a 1:1 ratio (CreERT2–) or Flt3−/−CD45.1+:Flt3−/−Csf1rf/fR26CreERT2/+CD45.2+ BM at a 1:1 ratio (CreERT2+). After
reconstitution and tamoxifen treatment to delete Csf1r, spleens and BM were analyzed by flow cytometry. (G) Shown are representative two-color histograms
(pregating, above plots; splenic B cells, B220+CD24+; splenic cDCs, CD11c+MHCII+; BM CSF1R+ cells, CD115+). Numbers specify the percentage of cells within the
indicated gates. (H) Summary data of the chimerism ratio of splenic cDCs presented as the ratio of CD45.1+ to CD45.2+ cDCs normalized to the ratio of CD45.1+
to CD45.2+ B cells within the same mouse. Dots represent individual mice; small horizontal lines indicate the mean. Data are pooled from four independent
experiments (n = 6–9 chimeras per genotype). ns, not significant (P > 0.05); *, P < 0.05; **, P < 0.01; ***, P < 0.001 using unpaired, two-tailed Student's t test.
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DC numbers seen in Flt3+/− mice conceivably results from the
combination of both normal Flt3L signaling and enhanced
M-CSF signaling contributing to DC development in these mice.
In contrast, in Flt3−/− mice only enhanced M-CSF signaling, but
not Flt3L signaling, contributes to DC development, and these
mice therefore have fewer DCs despite their even greater sensitivity to M-CSF.
We have not explored the biochemical basis for the altered
sensitivity observed in Flt3−/− DC progenitors. Conceivably, loss
of Flt3 increases the availability of shared signaling adaptor proteins such as Shc and Grb2 used by other class III RTKs (Dosil
et al., 1993; Rottapel et al., 1994; Verstraete and Savvides, 2012;
Tsapogas et al., 2017). The increased availability of these adaptors
could then allow other receptors acting through them to activate
downstream pathways more quickly and potently. Although the
exact mechanism remains to be uncovered, our results highlight
the potential for unintended consequences that may result when
manipulating the levels of signaling molecules in complex biological systems. The deletion of Flt3 appears to have ramifications beyond simply the loss of signaling by this receptor, and the
study of other receptor knockout mice may have similar caveats
that should be considered.
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APC (IM7); CD105 Biotin (MJ7/18); CD117 PE/Cy7 (2B8); CD172a
PerCP-eFluor 710 (P84); CD317 APC (eBio927); and F4/80 APCeFluor 780 (BM8). From Invitrogen: TCR Vα2 PE (B20.1) and
CD172a PerCP-eFluor 710 (P84). From Tonbo Biosciences: CD3e
Biotin (145-2C11); CD11c APC-Cy7 (N418); CD45.1 PE-Cy7 (A20);
and I-A/I-E V450 (M5/114.15.2). From BioLegend: CD4 APC (RM45); CD24 PE/Cy7 (M1/69); CD45.1 BV605 (A20); CD45.2 Alexa
Fluor 700 (104); CD115 BV711 (ASF98); Ly-6G Biotin (1A8); GFP
Alexa Fluor 488 (FM264G); Siglec H PE (551); Ter-119 Biotin (TER119); TCR Vα2 PE; and PerCP-Cy5.5 (B20.1). From Cell Signaling:
P-p44/42 MAPK (Erk1/2) (T202/Y204) PE (197G2). In general, all
antibodies were used at a dilution of 1:200 unless specified otherwise by the manufacturer. Cells were analyzed on a FACSCanto
II analyzer or FACSAria Fusion. Data were analyzed with FlowJo
software (TreeStar).
BM isolation and cell culture
BM was harvested from the femur, tibia, and pelvis. Bones were
fragmented by mortar and pestle in MACS buffer, and debris was
removed by passing cells through a 70-µm strainer. Red blood cells
were subsequently lysed with ammonium chloride-potassium
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bicarbonate lysis buffer. Cells were counted on a Vi-CELL analyzer (Beckman Coulter), and 3–5 × 106 cells were stained for
analysis. For Flt3L culture experiments, whole BM (8 × 106 cells in
4 ml cIMDM) was cultured at 37°C with 100 ng/ml Flt3L (Peprotech) or equivalent volume PBS (vehicle) for 9 d. For comparative
cytokine culture experiments, whole BM (6 × 106 cells in 4 ml of
cIMDM) was cultured at 37°C with 100 ng/ml Flt3L (Peprotech),
20 ng/ml M-CSF (Peprotech), 50 ng/ml SCF (Peprotech), or
equivalent volume PBS (vehicle) for 7 d. For all culture experiments, loosely adherent and suspension cells were harvested by
gentle pipetting at the indicated time point and stained with fluorescent antibodies for analysis by flow cytometry.
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Figure 8. Flt3−/− and Flt3l−/− BM progenitors and cDCs express normal levels of CSF1R and c-Kit. (A) BM cells from mice of the indicated genotypes were
analyzed by flow cytometry for cytokine receptor expression. Representative two-color histograms of live cells are shown. Numbers specify the percentage of
cells within the indicated gates. Data are representative of at least three independent experiments (n = 4–7 mice per genotype). (B) Pre-cDC1s and pre-cDC2s
from mice of the indicated genotypes were analyzed by flow cytometry for cytokine receptor expression levels. Representative one-color histograms of each
receptor are shown. Data are representative of three independent experiments (n = 3–7 mice per genotype). (C) Expression of the indicated genes in splenic
cDC1s and cDC2s from mice of the indicated genotypes was determined by gene expression microarray analysis. Dots represent biological replicates (n = 2
mice per subset per genotype).

In vivo Flt3L administration
Flt3+/+ or Flt3−/− mice were injected subcutaneously with sterile
saline (vehicle) or 10 µg of purified Flt3L-Fc fusion protein (generated in-house) daily for 8 d and analyzed on the following day.
Expression microarray analysis
Total RNA was extracted from sorted splenic DCs with an RNAqueous-Micro kit (Ambion), amplified with an Ovation Pico WTA
Journal of Experimental Medicine
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System (NuGEN), and hybridized to Mouse Gene 1.0 ST arrays
(Affymetrix). Expression values were analyzed after robust multiarray average summarization and quantile normalization using
ArrayStar 4 software (DNASTAR). All gene expression microarray data have been deposited in the NCBI Gene Expression Omnibus database with accession nos. GSE110789 and GSE110790.
Antigen presentation assays
In vitro cell-associated cross-presentation assays have been
described previously (Kretzer et al., 2016). In brief, Listeria
Durai et al.
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monocytogenes (LM)-OVA (a gift from H. Shen, University of
Pennsylvania, Philadelphia, PA) was grown in brain–heart infusion broth at 37°C for 6 h and then frozen overnight after dilution
plating for titer enumeration. Bacteria were subsequently thawed
and washed three times with PBS before heat killing at 80°C for
1 h and then freezing at −80°C. OT-I T cells were meanwhile sorted
from spleens of OT-I mice as B220–CD4–CD11c–CD45.1+CD8+Vα2+
and labeled with CFSE (eBioscience). Sort purity of >95% was
confirmed by post-sort analysis before cells were used for assays.
10,000 sorted splenic cDCs of the indicated subset from Flt3+/+
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Figure 9. Flt3−/− DC progenitors display increased sensitivity to M-CSF. (A and B) Serum-starved BM from mice of the indicated genotypes was treated
with M-CSF and assayed for phosphorylated Erk1/2 (pErk1/2) by intracellular flow cytometry. (A) Shown are representative one-color histograms of pErk1/2
in pre-cDC2s stimulated with the indicated concentrations of M-CSF. Numbers in black indicate the percentage of cells within the gate, and numbers in red
indicate the geometric MFI of pErk1/2 in the gated population. Data are representative of three independent experiments. (B) Summary data presented as the
integrated MFI of pErk1/2 in pre-cDC2s from mice of the indicated genotypes stimulated with the indicated concentration of M-CSF. Dots indicate the mean
from three independent experiments; error bars indicate the SEM (n = 3 mice per genotype). *, P < 0.05 using Student's t test.
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or Flt3−/− mice and 25,000 sorted CFSE-labeled OT-I T cells were
incubated with various doses of heat-killed LM-OVA for 3 d at
37°C. After incubation was complete, OT-I cells were assayed for
CFSE dilution and CD44 expression.
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Figure 10. Deletion of Flt3 rescues the severe DC defect in Flt3l−/− mice. (A–E) Splenocytes from mice of the indicated genotypes at 8-wk of age were
analyzed by flow cytometry for DC populations. (A) Shown are representative two-color histograms of live cells. Numbers specify the percentage of cells within
the indicated gates. (B–E) Summary data for the percentage (B) and number (C) of splenic cDCs and the percentage (D) and number (E) of splenic pDCs in mice
of the indicated genotypes. Dots represent biological replicates; small horizontal lines indicate the mean. Data are pooled from six independent experiments
(n = 4–5 mice per genotype). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using unpaired, two-tailed Student's t test.

For soluble OVA presentation assays, 10,000 sorted splenic
cDCs of the indicated subset from Flt3+/+ or Flt3−/− mice and
25,000 sorted CFSE-labeled OT-I T cells were incubated with
the indicated concentration of OVA (Worthington Biochemical
Journal of Experimental Medicine
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Corporation) for 3 d at 37°C. After incubation was complete, OT-I
T cells were assayed for CFSE dilution and CD44 expression.
Alternatively, sorted splenic cDCs of the indicated subset from
Flt3+/+ or Flt3−/− mice were incubated with 0.1 mg/ml of soluble
OVA (Worthington Biochemical Corporation) for 45 min at 37°C,
washed three times with PBS, and then different numbers of
cDCs were incubated with 25,000 sorted CFSE-labeled OT-I T
cells for 3 d at 37°C. After incubation was complete, OT-I T cells
were assayed for CFSE dilution and CD44 expression.

Progenitor sorting and culture
For sorting experiments, BM was isolated as described above
and depleted of CD3-, CD19-, CD105-, Ter119-, and Ly6G-expressing cells by staining with the corresponding biotinylated
antibodies followed by depletion with MagniSort Streptavidin Negative Selection beads (Thermo Fisher). The entirety
of the remaining BM was then stained with fluorescent antibodies before sorting. Gates used to define CDPs, pre-cDC1s,
and pre-cDC2s were based on previous studies (Onai et al.,
2007; Grajales-Reyes et al., 2015). CDPs were identified as Lin–
CD117intCD135+CD115+CD11c–MHCII–; pre-cDC1s as Lin–CD117int
CD11c+MHCIIintZbtb46-GFP+; and pre-cDC2s as Lin–CD117lo
CD115+CD11c+MHCII–Zbtb46-GFP+. Lineage markers included
CD3, CD19, CD105, Ter119, and Ly6G. A FACSAria Fusion was
used for sorting, and cells were sorted into cIMDM. Sort purity
of >95% was confirmed by post-sort analysis before cells were
used for further experiments. Sorted cells were cultured at 37°C
in 200 µl total volume of cIMDM with 100 ng/ml Flt3L (Peprotech), 20 ng/ml M-CSF (Peprotech), 50 ng/ml SCF (Peprotech),
or equivalent volume of PBS (vehicle) for 5 d.
For cell proliferation studies, sorted pre-cDC2s were washed
three times with PBS to remove serum and then incubated with
10 µM of eBioscience Cell Proliferation Dye eFluor 450 (Thermo
Fisher) at 37°C for 10 min. Reaction was quenched by the direct
addition of FCS, and cells were washed three times with cIMDM.
Cells were subsequently cultured at 37°C in 200 µl total volume
of cIMDM with 20 ng/ml M-CSF (Peprotech) for 5 d.
Tamoxifen administration
Mice were orally gavaged with 4 mg tamoxifen (Sigma-Aldrich)
dissolved in corn oil (Sigma-Aldrich) for an initial loading dose
and then placed on tamoxifen citrate chow (Envigo) for 4–5 wk.
Mice were given up to 2 d of regular chow per week if significant
weight loss was observed. After treatment, mice were rested on
regular chow for one week before analysis. Deletion of CSF1R in
the BM was confirmed in all mice.
Durai et al.
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BM progenitor cytokine stimulation
BM was isolated and lineage-depleted as described above. Lin– BM
cells were then aliquoted at 106 cells per condition and serumstarved in plain IMDM for 4 h at 37°C. After starvation, M-CSF was
added at the indicated concentrations, and cells were incubated at
37°C for 5 min for stimulation. Cells were then fixed for 15 min at
room temperature by adding paraformaldehyde (Electron Microscopy Sciences) directly to cells to a final concentration of 2%. Cells
were washed twice with MACS buffer and then permeabilized by
adding ice-cold methanol directly to cells with gentle vortexing,
followed by incubation at 4°C for 30 min. Cells were again washed
twice with MACS buffer and then stained with fluorescent antibodies against cell surface and intracellular antigens for 30 min at
room temperature. Antibodies were previously tested individually
to ensure their functionality in fixed and permeabilized cells. Flow
cytometric analyses were then performed on stained cells. For
analysis, we used integrated mean fluorescence intensity (iMFI),
which combines frequency and MFI into a single measure of total
functional response (Darrah et al., 2007; Shooshtari et al., 2010).
Statistical analysis
All statistical analyses were performed using Prism 7 (GraphPad
Software). Statistical significance was evaluated using unpaired
two-tailed Student's t test unless otherwise noted. Differences
with P ≤ 0.05 were considered significant. n represents the number of biological replicates.
Online supplemental material
Fig. S1 shows the percentage of cDCs and pDCs in SLNs and
lungs from the mice strains analyzed in Figs. 1 and 2. Fig. S2
shows the number of cDCs developing from the in vitro cytokine cultures from Fig. 5 and the expression of various costimulatory molecules on these cDCs. Fig. S3 shows the development
of pDCs from the in vitro cytokine cultures from Fig. 5 and the
development of pDCs from sorted CDPs treated with various
cytokines from Fig. 6. Fig. S4 shows the continued development of pre-cDC1s and pre-cDC2s in Flt3l−/− mice and that the
pre-cDC2s from Flt3l−/− mice are no more sensitive to M-CSF
than the pre-cDC2s from Flt3l+/+ mice. Fig. S5 depicts that the
deletion of Flt3 in Flt3l−/− mice reverses the severe DC defect in
SLNs and lungs.
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Type I interferon production from pDCs
25,000 sorted pDCs from Flt3+/+ or Flt3−/− mice were incubated
overnight at 37°C in cIMDM with 100 ng/ml Flt3L plus either 6
µg/ml of CpG-A oligodeoxynucleotides or the equivalent volume
of PBS (vehicle). The next day cells were spun down and the
supernatant was collected. IFN-α in the supernatant was measured using the PBL Verikine Mouse IFN Alpha All Subtype ELISA
kit, High Sensitivity (PBL Assay Science).

BM chimeras
BM cells from donor mice were collected as described above. To
generate mixed BM chimeras, BM cells were isolated from mice
of the appropriate genotypes, counted with a Vi-CELL analyzer
(Beckman Coulter), and mixed at a ratio of 1:1 before transplantation. Recipient mice received a single dose of 1050 rads of wholebody irradiation and then received a transplant of 10 × 106 total
BM cells the following day. Mice were allowed to reconstitute for
8–10 wk before further experiments or analyses were conducted.
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